Systematic Review Article

Extracellular Vesicles from Stromal Vascular Fraction of Human Adipose Tissue in the Development of Non-antibiotic Therapy

Author(s): V.M.H. Srinivasa, B.M. Kumar, Prakash Patil, Nikhil Shetty and A.V. Shetty*

Volume 24, Issue 12, 2023

Published on: 11 September, 2023

Page: [981 - 997] Pages: 17

DOI: 10.2174/1389450124666230907093413

Price: $65

Abstract

Background: Antibiotic-resistant microorganisms (ARMS) are the leading cause of socio- economic loss in the world, with historical evidence linking them to increased mortality and morbidity.

Methodology: In this systematic review, we highlight a new treatment approach for antibiotic-resistant infections using 'Extracellular vesicle (EVs)-based therapy,' also known as cell- and drug-free therapy. Here, we categorize and summarize studies on EVs derived from various human sources, such as tissues, bodily fluids, or their condition media, emphasizing their anti-infective properties in the treatment of various infections. In addition, we contend that human adipose tissue (HAT) is a superior source of antimicrobial EVs (aEVs) and investigate the distinct antimicrobial properties of aEVs derived from a stromal vascular fraction (SVF) of human adipose tissue. In light of this, we described the limited literature and research gaps that are essential for using SVF-aEVs as personalized precision medicine.

Result and Discussion: The notion behind adipose-derived SVF-EVs is supported by extensive literature searches that demonstrate growing trends in EV-based medical treatments as well as the larger therapeutic potential of HAT because of its extensive history of usage in regenerative medicine.

Conclusion: Additionally, the underlying science that explains how the inflammatory process aids in the clearance of infections and the restoration of homeostasis after the host immune system successfully defends against foreign pathogens, as well as the fact that adipose-derived SVF is a noninvasive, cost-effective source of a variety of parent immune cells that produces a good yield of EVs with the same genetic make-up as their parent cells, make this concept worthwhile. This research may thereby increase survival rates and survival quality in cases of resistant infections.

Vocabulary: Drug- and cell-free therapy = Nano molecules (extracellular vesicles) used as a therapeutic source without the need for chemical drugs or cell transplantation. Anti-infection EVs (aEVs) = Nature’s own anti-infection powered EVs (unmodified).

Keywords: Antimicrobial extracellular vesicles, human adipose tissue, stromal vascular fraction, immunomodulation, Antibiotic- resistant microbes, TNF-alpha.

« Previous
Graphical Abstract
[1]
Preeja PP, Kumar SH, Shetty V. Prevalence and characterization of methicillin-resistant Staphylococcus aureus from Community- and hospital-associated infections: A tertiary care center study. Antibiotics 2021; 10(2): 197.
[http://dx.doi.org/10.3390/antibiotics10020197] [PMID: 33670648]
[2]
Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: A rundown of a global crisis. Infect Drug Resist 2018; 11: 1645-58.
[http://dx.doi.org/10.2147/IDR.S173867] [PMID: 30349322]
[3]
Neill JO. Antimicrobial resistance: Tackling a crisis for the health and wealth of nations the review on antimicrobial resistance chaired. 2014.
[4]
de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 2016; 13(11): e1002184.
[http://dx.doi.org/10.1371/journal.pmed.1002184] [PMID: 27898664]
[5]
Malloci M, Perdomo L, Veerasamy M, Andriantsitohaina R, Simard G, Martínez MC. Extracellular vesicles: Mechanisms in human health and disease. Antioxid Redox Signal 2019; 30(6): 813-56.
[http://dx.doi.org/10.1089/ars.2017.7265] [PMID: 29634347]
[6]
Stremersch S, De Smedt SC, Raemdonck K. Therapeutic and diagnostic applications of extracellular vesicles. J Control Release 2016; 244(Pt B): 167-83.
[http://dx.doi.org/10.1016/j.jconrel.2016.07.054] [PMID: 27491882]
[7]
Silva AM, Teixeira JH, Almeida MI, Gonçalves RM, Barbosa MA, Santos SG. Extracellular vesicles: Immunomodulatory messengers in the context of tissue repair/regeneration. Eur J Pharm Sci 2017; 98: 86-95.
[http://dx.doi.org/10.1016/j.ejps.2016.09.017] [PMID: 27644894]
[8]
Zaborowski MP, Balaj L, Breakefield XO, Lai CP. Extracellular vesicles: Composition, biological relevance, and methods of study. Bioscience 2015; 65(8): 783-97.
[http://dx.doi.org/10.1093/biosci/biv084] [PMID: 26955082]
[9]
Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 2013; 200(4): 373-83.
[http://dx.doi.org/10.1083/jcb.201211138] [PMID: 23420871]
[10]
Bazzan E, Tinè M, Casara A, et al. Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to Today. Int J Mol Sci 2021; 22(12): 6417.
[http://dx.doi.org/10.3390/ijms22126417] [PMID: 34203956]
[11]
Tang TT, Wang B, Lv LL, Liu BC. Extracellular vesicle-based nanotherapeutics: Emerging frontiers in anti-inflammatory therapy. Theranostics 2020; 10(18): 8111-29.
[http://dx.doi.org/10.7150/thno.47865] [PMID: 32724461]
[12]
Eleraky NE, Allam A, Hassan SB, Omar MM. Nanomedicine fight against antibacterial resistance: An overview of the recent pharmaceutical innovations. Pharmaceutics 2020; 12(2): 142.
[http://dx.doi.org/10.3390/pharmaceutics12020142] [PMID: 32046289]
[13]
Yáñez-Mó M, Siljander PRM, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015; 4(1): 27066.
[http://dx.doi.org/10.3402/jev.v4.27066] [PMID: 25979354]
[14]
Manchon E, Hirt N, Bouaziz JD, Jabrane-Ferrat N, Al-Daccak R. Stem cells-derived extracellular vesicles: Potential therapeutics for wound healing in chronic inflammatory skin diseases. Int J Mol Sci 2021; 22(6): 3130.
[http://dx.doi.org/10.3390/ijms22063130] [PMID: 33808520]
[15]
Russell AE, Sneider A, Witwer KW, et al. Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: An ISEV position paper arising from the ISEV membranes and EVs workshop. J Extracell Vesicles 2019; 8(1): 1684862.
[http://dx.doi.org/10.1080/20013078.2019.1684862] [PMID: 31762963]
[16]
Tricarico C, Clancy J, D’Souza-Schorey C. Biology and biogenesis of shed microvesicles. Small GTPases 2017; 8(4): 220-32.
[http://dx.doi.org/10.1080/21541248.2016.1215283] [PMID: 27494381]
[17]
Lindenbergh MFS, Stoorvogel W. Antigen presentation by extracellular vesicles from professional antigen-presenting cells. Annu Rev Immunol 2018; 36(1): 435-59.
[http://dx.doi.org/10.1146/annurev-immunol-041015-055700] [PMID: 29400984]
[18]
Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 2014; 14(3): 195-208.
[http://dx.doi.org/10.1038/nri3622] [PMID: 24566916]
[19]
Schorey JS, Cheng Y, Singh PP, Smith VL. Exosomes and other extracellular vesicles in host–pathogen interactions. EMBO Rep 2015; 16(1): 24-43.
[http://dx.doi.org/10.15252/embr.201439363] [PMID: 25488940]
[20]
Bröker B, Mrochen D, Péton V. The T cell response to staphylococcus aureus. Pathogens 2016; 5(1): 31.
[http://dx.doi.org/10.3390/pathogens5010031] [PMID: 26999219]
[21]
Hartjes T, Mytnyk S, Jenster G, van Steijn V, van Royen M. Extracellular vesicle quantification and characterization: common methods and emerging approaches. Bioengineering 2019; 6(1): 7.
[http://dx.doi.org/10.3390/bioengineering6010007] [PMID: 30654439]
[22]
Zhang W, Jiang X, Bao J, Wang Y, Liu H, Tang L. Exosomes in pathogen infections: A bridge to deliver molecules and link functions. Front Immunol 2018; 9(FEB): 90.
[http://dx.doi.org/10.3389/fimmu.2018.00090] [PMID: 29483904]
[23]
Bautista-Hernández LA, Gómez-Olivares JL, Buentello-Volante B, Bautista-de Lucio VM. Fibroblasts: The unknown sentinels eliciting immune responses against microorganisms. Eur J Microbiol Immunol 2017; 7(3): 151-7.
[http://dx.doi.org/10.1556/1886.2017.00009] [PMID: 29034104]
[24]
Jeppesen DK, Fenix AM, Franklin JL, et al. Reassessment of exosome composition. Cell 2019; 177(2): 428-445.e18.
[http://dx.doi.org/10.1016/j.cell.2019.02.029] [PMID: 30951670]
[25]
Börger V, Bremer M, Ferrer-Tur R, et al. Mesenchymal stem/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents. Int J Mol Sci 2017; 18(7): 1450.
[http://dx.doi.org/10.3390/ijms18071450] [PMID: 28684664]
[26]
Schipper HS, Prakken B, Kalkhoven E, Boes M. Adipose tissue-resident immune cells: Key players in immunometabolism. Trends Endocrinol Metab 2012; 23(8): 407-15.
[http://dx.doi.org/10.1016/j.tem.2012.05.011] [PMID: 22795937]
[27]
Palumbo P, Lombardi F, Siragusa G, Cifone M, Cinque B, Giuliani M. Methods of isolation, characterization and expansion of human adipose-derived stem cells (ASCs): An overview. Int J Mol Sci 2018; 19(7): 1897.
[http://dx.doi.org/10.3390/ijms19071897] [PMID: 29958391]
[28]
Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int 2012; 2012: 1-11.
[http://dx.doi.org/10.1155/2012/812693] [PMID: 22577397]
[29]
Bourgeois C, Gorwood J, Barrail-Tran A, et al. Specific biological features of adipose tissue, and their impact on HIV persistence. Front Microbiol 2019; 10(December): 2837.
[http://dx.doi.org/10.3389/fmicb.2019.02837] [PMID: 31921023]
[30]
Priglinger E, Strohmeier K, Weigl M, et al. SVF-derived extracellular vesicles carry characteristic miRNAs in lipedema. Sci Rep 2020; 10(1): 7211.
[http://dx.doi.org/10.1038/s41598-020-64215-w] [PMID: 32350368]
[31]
Wong DE, Banyard DA, Santos PJF, Sayadi LR, Evans GRD, Widgerow AD. Adipose-derived stem cell extracellular vesicles: A systematic review. J Plast Reconstr Aesthet Surg 2019; 72(7): 1207-18.
[http://dx.doi.org/10.1016/j.bjps.2019.03.008] [PMID: 30952587]
[32]
Lőrincz ÁM, Timár CI, Marosvári KA, et al. Effect of storage on physical and functional properties of extracellular vesicles derived from neutrophilic granulocytes. J Extracell Vesicles 2014; 3(1): 25465.
[http://dx.doi.org/10.3402/jev.v3.25465] [PMID: 25536933]
[33]
Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (misev2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018; 7(1): 1535750.
[http://dx.doi.org/10.1080/20013078.2018.1535750] [PMID: 30637094]
[34]
Ogura F, Wakao S, Kuroda Y, et al. Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: Potential implications in regenerative medicine. Stem Cells Dev 2014; 23(7): 717-28.
[http://dx.doi.org/10.1089/scd.2013.0473] [PMID: 24256547]
[35]
Bora P, Majumdar AS. Adipose tissue-derived stromal vascular fraction in regenerative medicine: A brief review on biology and translation. Stem Cell Res Ther 2017; 8(1): 145.
[http://dx.doi.org/10.1186/s13287-017-0598-y] [PMID: 28619097]
[36]
Gentile P, Sterodimas A, Pizzicannella J, et al. Systematic review: Allogenic use of stromal vascular fraction (SVF) and decellularized extracellular matrices (ECM) as advanced therapy medicinal products (ATMP) in tissue regeneration. Int J Mol Sci 2020; 21(14): 4982.
[http://dx.doi.org/10.3390/ijms21144982] [PMID: 32679697]
[37]
Samanta S, Rajasingh S, Drosos N, Zhou Z, Dawn B, Rajasingh J. Exosomes: New molecular targets of diseases. Acta Pharmacol Sin 2018; 39(4): 501-13.
[http://dx.doi.org/10.1038/aps.2017.162] [PMID: 29219950]
[38]
Cai Y, Li J, Jia C, He Y, Deng C. Therapeutic applications of adipose cell-free derivatives: A review. Stem Cell Res Ther 2020; 11(1): 312.
[http://dx.doi.org/10.1186/s13287-020-01831-3] [PMID: 32698868]
[39]
Rodrigues M, Fan J, Lyon C, Wan M, Hu Y. Role of extracellular vesicles in viral and bacterial infections: Pathogenesis, diagnostics, and therapeutics. Theranostics 2018; 8(10): 2709-21.
[http://dx.doi.org/10.7150/thno.20576] [PMID: 29774070]
[40]
Brakhage A A, Zimmermann A-K, Rivieccio F, Visser C, Blango M G. Host-derived extracellular vesicles for antimicrobial defense. microLife 2021; 2(March): 1-10.
[http://dx.doi.org/10.1093/femsml/uqab003]
[41]
Varkouhi AK, Jerkic M, Ormesher L, Gagnon S, Goyal S, Rabani R, et al. Extracellular vesicles human umbilical cord coli: Induced acute lung injury in rats. Anesthesiology 2019; 130(5): 778-90.
[http://dx.doi.org/10.1097/ALN.0000000000002655] [PMID: 30870158]
[42]
Monsel A, Zhu Y, Gennai S, et al. Therapeutic effects of human mesenchymal stem cell–derived microvesicles in severe pneumonia in mice. Am J Respir Crit Care Med 2015; 192(3): 324-36.
[http://dx.doi.org/10.1164/rccm.201410-1765OC] [PMID: 26067592]
[43]
Alvarez-Jiménez VD, Leyva-Paredes K, García-Martínez M, et al. Extracellular vesicles released from mycobacterium tuberculosis-infected neutrophils promote macrophage autophagy and decrease intracellular mycobacterial survival. Front Immunol 2018; 9(FEB): 272.
[http://dx.doi.org/10.3389/fimmu.2018.00272] [PMID: 29520273]
[44]
Morrison TJ, Jackson MV, Cunningham EK, et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med 2017; 196(10): 1275-86.
[http://dx.doi.org/10.1164/rccm.201701-0170OC] [PMID: 28598224]
[45]
Huang R, Qin C, Wang J, et al. Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury. Aging 2019; 11(18): 7996-8014.
[http://dx.doi.org/10.18632/aging.102314] [PMID: 31575829]
[46]
Wang J, Huang R, Xu Q, et al. Mesenchymal stem cell–derived extracellular vesicles alleviate acute lung injury via transfer of miR-27a-3p. Crit Care Med 2020; Publish Ahead of Print(7): e599-610.
[http://dx.doi.org/10.1097/CCM.0000000000004315] [PMID: 32317602]
[47]
Song Y, Dou H, Li X, et al. Exosomal miR-146a contributes to the enhanced therapeutic efficacy of interleukin-1β-primed mesenchymal stem cells against sepsis. Stem Cells 2017; 35(5): 1208-21.
[http://dx.doi.org/10.1002/stem.2564] [PMID: 28090688]
[48]
Reid VL, Webster NR. Role of microparticles in sepsis. Br J Anaesth 2012; 109(4): 503-13.
[http://dx.doi.org/10.1093/bja/aes321] [PMID: 22952169]
[49]
Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95(3): 930-5.
[http://dx.doi.org/10.1182/blood.V95.3.930.003k46_930_935] [PMID: 10648405]
[50]
Lőrincz ÁM, Bartos B, Szombath D, et al. Role of Mac-1 integrin in generation of extracellular vesicles with antibacterial capacity from neutrophilic granulocytes. J Extracell Vesicles 2020; 9(1): 1698889.
[http://dx.doi.org/10.1080/20013078.2019.1698889] [PMID: 31853340]
[51]
Timár CI, Lőrincz ÁM, Csépányi-Kömi R, et al. Antibacterial effect of microvesicles released from human neutrophilic granulocytes. Blood 2013; 121(3): 510-8.
[http://dx.doi.org/10.1182/blood-2012-05-431114] [PMID: 23144171]
[52]
Shiekh PA, Singh A, Kumar A. Data supporting exosome laden oxygen releasing antioxidant and antibacterial cryogel wound dressing OxOBand alleviate diabetic and infectious wound healing. Data Brief 2020; 31: 105671.
[http://dx.doi.org/10.1016/j.dib.2020.105671] [PMID: 32462062]
[53]
Oehmcke S, Westman J, Malmström J, et al. A novel role for pro-coagulant microvesicles in the early host defense against streptococcus pyogenes. PLoS Pathog 2013; 9(8): e1003529.
[http://dx.doi.org/10.1371/journal.ppat.1003529] [PMID: 23935504]
[54]
Fleming A, Hobbs H, Giroux V. Amplifying Host Innate Immunity through - ProQuest. J Extracell Vesicles suppl 2018; 7: 179.
[55]
Hu P, Yang Q, Wang Q, et al. Mesenchymal stromal cells-exosomes: A promising cell-free therapeutic tool for wound healing and cutaneous regeneration. Burns Trauma 2019; 7(38): s41038-019-0178-8.
[http://dx.doi.org/10.1186/s41038-019-0178-8] [PMID: 31890717]
[56]
Yagi H, Chen AF, Hirsch D, et al. Antimicrobial activity of mesenchymal stem cells against staphylococcus aureus. Stem Cell Res Ther 2020; 11(1): 293.
[http://dx.doi.org/10.1186/s13287-020-01807-3] [PMID: 32680544]
[57]
Conese M, Annacontini L, Carbone A, et al. The role of adipose-derived stem cells, dermal regenerative templates, and platelet-rich plasma in tissue engineering-based treatments of chronic skin wounds. Stem Cells Int 2020; 2020(1): 17.
[http://dx.doi.org/10.1155/2020/7056261]
[58]
Li J, Li D, Liu X, Tang S, Wei F. Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. J Inflamm 2012; 9(1): 33.
[http://dx.doi.org/10.1186/1476-9255-9-33] [PMID: 22974286]
[59]
Chow L, Johnson V, Impastato R, Coy J, Strumpf A, Dow S. Antibacterial activity of human mesenchymal stem cells mediated directly by constitutively secreted factors and indirectly by activation of innate immune effector cells. Stem Cells Transl Med 2020; 9(2): 235-49.
[http://dx.doi.org/10.1002/sctm.19-0092] [PMID: 31702119]
[60]
Yan Y, Zhou W, Wang Y, et al. The potential role of extracellular vesicles in COVID-19 treatment: Opportunity and challenge. Front Mol Biosci 2021; 8(July): 699929.
[http://dx.doi.org/10.3389/fmolb.2021.699929] [PMID: 34368228]
[61]
Pillalamarri N, Abdullah , Ren G, et al. Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage. Transl Oncol 2021; 14(7): 101095.
[http://dx.doi.org/10.1016/j.tranon.2021.101095] [PMID: 33887552]
[62]
Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev 2020; 29(12): 747-54.
[http://dx.doi.org/10.1089/scd.2020.0080] [PMID: 32380908]
[63]
Oh SJ, Lee EN, Park JH, et al. Anti-viral activities of umbilical cord mesenchymal stem cell-derived small extracellular vesicles against human respiratory viruses. Front Cell Infect Microbiol 2022; 12(April): 850744.
[http://dx.doi.org/10.3389/fcimb.2022.850744] [PMID: 35558099]
[64]
Li S, Zhu A, Ren K, Li S, Chen L. IFNβ-induced exosomal linc-EPHA6-1 promotes cytotoxicity of NK cells by acting as a ceRNA for hsa-miR-4485-5p to up-regulate NKp46 expression. Life Sci 2020; 257(May): 118064.
[http://dx.doi.org/10.1016/j.lfs.2020.118064] [PMID: 32652136]
[65]
Madison MN, Jones PH, Okeoma CM. Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex. Virology 2015; 482: 189-201.
[http://dx.doi.org/10.1016/j.virol.2015.03.040] [PMID: 25880110]
[66]
Smith JA, Daniel R. Human vaginal fluid contains exosomes that have an inhibitory effect on an early step of the HIV-1 life cycle. AIDS 2016; 30(17): 2611-6.
[http://dx.doi.org/10.1097/QAD.0000000000001236] [PMID: 27536982]
[67]
Qian X, Xu C, Fang S, et al. Exosomal MicroRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis c virus infection. Stem Cells Transl Med 2016; 5(9): 1190-203.
[http://dx.doi.org/10.5966/sctm.2015-0348] [PMID: 27496568]
[68]
Giugliano S, Kriss M, Golden-Mason L, et al. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication. Gastroenterology 2015; 148(2): 392-402.e13.
[http://dx.doi.org/10.1053/j.gastro.2014.10.040] [PMID: 25447848]
[69]
Zhou Y, Wang X, Sun L, et al. Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes. FASEB J 2016; 30(12): 4132-40.
[http://dx.doi.org/10.1096/fj.201600696R] [PMID: 27605546]
[70]
Halder LD, Abdelfatah MA, Jo EAH, et al. Factor H Binds to Extracellular DNA Traps Released from Human Blood Monocytes in Response to Candida albicans. Front Immunol 2017; 7(JAN): 671.
[http://dx.doi.org/10.3389/fimmu.2016.00671] [PMID: 28133459]
[71]
Shopova IA, Belyaev I, Dasari P, et al. Human neutrophils produce antifungal extracellular vesicles against aspergillus fumigatus. MBio 2020; 11(2): e00596-20.
[http://dx.doi.org/10.1128/mBio.00596-20] [PMID: 32291301]
[72]
Hu G, Gong AY, Roth AL, et al. Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathog 2013; 9(4): e1003261.
[http://dx.doi.org/10.1371/journal.ppat.1003261] [PMID: 23592986]
[73]
Cheng Y, Schorey JS. Extracellular vesicles deliver MycobacteriumRNA to promote host immunity and bacterial killing. EMBO Rep 2019; 20(3): e46613.
[http://dx.doi.org/10.15252/embr.201846613] [PMID: 30683680]
[74]
Spinosa M, Lu G, Su G, et al. Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147. FASEB J 2018; 32(11): 6038-50.
[http://dx.doi.org/10.1096/fj.201701138RR] [PMID: 29812968]
[75]
Porzionato A, Zaramella P, Dedja A, et al. Intratracheal administration of clinical-grade mesenchymal stem cell-derived extracellular vesicles reduces lung injury in a rat model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2019; 316(1): L6-L19.
[http://dx.doi.org/10.1152/ajplung.00109.2018] [PMID: 30284924]
[76]
You J, Zhou O, Liu J, et al. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles alleviate lung injury in rat model of bronchopulmonary dysplasia by affecting cell survival and angiogenesis. Stem Cells Dev 2020; 29(23): 1520-32.
[http://dx.doi.org/10.1089/scd.2020.0156] [PMID: 33040709]
[77]
Kim S, Maeng J, Hyun SJ, et al. Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis. Theranostics 2020; 10(11): 5011-28.
[http://dx.doi.org/10.7150/thno.42742] [PMID: 32308765]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy